logo

For the Inventor, By the Inventor

Hinterbrühl, Austria

Tobias Wunberg

This inventor holds 30 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 1 EPO patent, primarily in Antiviral Agents. Top assignees: Boehringer Ingelheim International Gmbh, Aicuris Gmbh + Co. Kg., Bayer Schering Pharma Ag. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tobias Wunberg. Retrieved from https://idiyas.com/inventor/tobias-wunberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 93.3



Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Hinterbrühl, AT (2010)
  • Solingen, DE (2006 - 2011)
  • Hinterbruehl, AU (2012)
  • Hinterbruehl, AT (2012 - 2024)

Company Filing History:

goldMedal19 out of 1,562 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal5 out of 53 
 
Aicuris Gmbh + Co. Kg.
 patents
bronzeMedal3 out of 192 
 
Bayer Schering Pharma Ag
 patents
4. 2 out of 77 
 
Bayer Healthcare Aktiengesellschaft
 patents
5. 1 out of 12,268 
 
Bayer Aktiengesellschaft
 patents
6. 1 out of 1,221 
 
Vanderbilt University
 patents
where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
EGFR Inhibitors
Cancer Treatment
SOS1 Inhibitors
MDM2-P53 Inhibitors
Phosphatidylinositol-3-Kinases
Aryl Sulfonamides
Dihydroquinazolines
Heterocycles
Thiazolyl-Dihydro-Indazoles
Antiviral Action
Substituted Quinazolines
5-Alkynyl-Pyridines
30 patents (USPTO):Explore Patents
1. 12064421 - Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors (2024-08-20),
2. 12060367 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer (2024-08-13),
3. 12053473 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors (2024-08-06),
4. 11814380 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors (2023-11-14),
5. 10898487 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors (2021-01-26),
6. 10829487 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors (2020-11-10),
7. 10576064 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2020-03-03),
8. 10138251 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2018-11-27),
9. 9321771 - 5-alkynyl-pyrimidines (2016-04-26),
10. 9243000 - Thia-triaza-indacenes (2016-01-26),
11. 9090564 - 5-alkynyl-pyridines (2015-07-28),
12. 8916548 - 5-alkynyl-pyrimidines (2014-12-23),
13. 8653097 - Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor (2014-02-18),
14. 8633183 - 5-alkynyl-pyrimidines (2014-01-21),
15. 8618111 - 5-alkynyl-pyrimidines (2013-12-31),

Title: Tobias Wunberg: Pioneering Innovation for a Sustainable Future

Introduction: Tobias Wunberg, a visionary inventor based in Hinterbruehl, AT, is at the forefront of technological advancements with his passion for innovation and commitment to creating a sustainable future. His relentless pursuit of groundbreaking solutions has cemented his status as a true pioneer in the world of technology, inspiring others to think outside the box and push the boundaries of what is achievable.

Latest Patents: With an impressive portfolio of 27 patents, Tobias Wunberg's latest inventions include "Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors" and "Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors." These patents showcase his expertise in developing cutting-edge solutions for treating and preventing oncological diseases, positioning him as a trailblazer in the field of medicine and pharmaceuticals.

Career Highlights: Having worked with renowned companies such as Boehringer Ingelheim International GmbH and Aicuris GmbH & Co. KG, Tobias Wunberg has honed his skills and expertise in driving innovation and technological advancement. His innovative approach to problem-solving and his dedication to creating impactful solutions have earned him recognition within the industry as a leader in his field.

Collaborations: Throughout his career, Tobias Wunberg has collaborated with esteemed colleagues such as Holger Zimmermann and Kerstin Henninger, fostering a culture of innovation and collaboration. By working closely with like-minded individuals, he has been able to leverage collective expertise and drive towards common goals, further solidifying his reputation as a visionary inventor.

Conclusion: In conclusion, Tobias Wunberg's unwavering commitment to innovation, coupled with his dedication to creating a more sustainable future, sets him apart as a true luminary in the world of technology. His inventive spirit and pioneering inventions continue to inspire others to think creatively and strive for excellence, making him a driving force in shaping the future of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…